Autres langues Pfizer, Inc.

Actions

PFE

US7170811035

Marché Fermé - Nyse Autres places de cotation 22:01:17 09/09/2024			Après clotûre 01:27:48
29,41 ^USD	+2,98 %		29,46	+0,17 %

06/09	Basilea Pharmaceutica obtient un paiement d'étape de 25 millions de dollars de Pfizer	MT
06/09	Basilea perçoit un versement d'étape de 25 millions pour Cresemba	AW

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Basilea Pharmaceutica Ltd - Strong Cresemba sales performance in Europe triggers USD 25 million sales Milestone Payment to Basilea	09/09
InflexionPoint Announces Appointment of Digital Transformation Executive to Board of Directors	09/09
A mural honoring scientists hung in Pfizer's NYC lobby for 60 years. Now it's up for grabs	07/09
Aktien Schweiz schwächer - Schwache Wall Street dämpft Stimmung	06/09
Basilea Pharmaceutica Secures $25 Million Milestone Payment from Pfizer	06/09
Basilea erhält weitere Meilensteinzahlung für Cresemba	06/09
Pfizer : Morgan Stanley 22nd Annual Global Healthcare Conference Transcript	05/09
CareRx Corporation Appoints Suzanne Brand as Chief Financial Officer, Effective October 1, 2024	05/09
Pfizer Appoints Elif Aral as Regional President for Middle East, Russia, and Africa	05/09
FDA Approves Moderna's And Pfizer/BioNTech's Updated COVID-19 Vaccines	04/09
Pfizer : Morgan Stanley 22nd Annual Global Healthcare Conference Event Announcement	04/09
Health Care Losses Limited By Vaxcyte's Surge - Health Care Roundup	03/09
Acepodia Enters Strategic Clinical Collaboration with Pfizer to Accelerate Development of Antibody-Cell Conjugation-Based Cell Therapies in Autoimmune Diseases	03/09
Pfizer : August Social Media Round-Up—the Summer Games, Girls Who Code, and More	03/09
Vaxcyte's shares hit record high on early data on pneumococcal vaccine	03/09
EEUU pagará al menos el doble que otros países por medicamentos tras negociación	03/09
Pfizer, Valneva Report Positive Lyme Disease Vaccine Candidate Data	03/09
US will still pay at least twice as much after negotiating drug prices	03/09
Valneva, Pfizer's Second Lyme Disease Booster Shot Shows Antibody Response in Phase 2 Study	03/09
Valneva SE and Pfizer Inc. Report Further Positive Phase 2 Booster Results for Lyme Disease Vaccine Candidate	03/09

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

A la une

Pfizer, Inc. : Un cycle pour rien ?

Le 14 décembre 2023 à 12:06

Albert Bourla, PDG de Pfizer (interview complète) : ARNm, acquisitions, médicaments pour la perte de poids

Le 31 octobre 2023 à 21:50